Table 3.
| Variable | No opioids group |
P value | Opioids group |
P value | ||
|---|---|---|---|---|---|---|
| Admission | Dismissal | Admission | Dismissal | |||
| Anticonvulsants | 0.36±0.616 | 0.13±0.42 | .09 | 0.71±0.65 | 0.17±0.461 | <.0001 |
| Antidepressants | 1.81±0.696 | 1.0±0.173 | <.0001 | 1.84±0.752 | 1.05±0.265 | <.0001 |
| Barbiturates | 0.06±0.237 | 0.04±0.207 | .97 | 0.02±0.153 | 0.04±0.187 | .98 |
| Benzodiazepines | 0.31±0.495 | 0.66±0.65 | .001 | 0.03±0.17 | 0.02±0.15 | <.0001 |
| Stimulants | 0.01±0.121 | 0.01±0.121 | .99 | 0.08±0.387 | 0.08±0.387 | .99 |
| Triptans | 0.16±0.409 | 0.06±0.293 | .32 | 0.12±0.361 | 0.07±0.339 | .82 |
| Cannabinoids | 0 | 0 | NA | 0.02±0.153 | 0.02±0.153 | .35 |
| NSAIDs | 0.81±0.885 | 0.48±0.72 | .09 | 0.92±0.934 | 0.57±0.68 | .03 |
| Opioids | 0 | 0 | NA | 1.4±0.76 | 0.13±0.422 | <.0001 |
| Corticosteroids | 0.04±0.207 | 0.01±0.121 | .77 | 0.07±0.259 | 0 | .05 |
| Antiemetics | 0.13±0.42 | 0.16±0.476 | .98 | 0.36±0.593 | 0.34±0.566 | .99 |
| Antispasmodics | 0.09±0.286 | 0 | .07 | 0.07±0.302 | 0 | .12 |
| Muscle relaxants | 0.16±0.507 | 0.10±0.306 | .89 | 0.42±0.54 | 0.35±0.525 | .77 |
| Supplements/vitamins | 1.72±2.265 | 0.37±0.944 | .0004 | 2.11±2.574 | 0.41±1.271 | <.0001 |
| Topical | 0.16±0.409 | 0.19±0.395 | .99 | 0.46±0.664 | 0.43±0.715 | .99 |
| Total No. of medications | 7.33±3.405 | 3.85±1.91 | <.0001 | 10.7±4.179 | 6.4±2.879 | <.0001 |
| Total OMEs | 0 | 0 | NA | 60.33±65.82 | 2.14±7.95 | <.0001 |
| Total LMEs | 0.65±1.349 | 0.09±0.728 | .35 | 2.23±3.441 | 0.17±0.717 | <.0001 |
LME, lorazepam milligram equivalent; NA, not applicable; NSAID, nonsteroidal anti-inflammatory drug; OME, oral morphine equivalent.
Data are presented as mean ± SD.